ClearOne is trading 6.05% down at $4.19, apparently on trading-specific selling or profit-taking; the catalyst is unconfirmed.
- September 21’s $4.46 close followed a 5.69% gain; no new company-specific negative announcement or reliable report explaining the September 22 decline was identified.
- The latest catalyst is Vivani Medical’s expectation that the Cortigent merger with ClearOne will price and close in October 2026; that positive news does not explain the reversal, and the higher technology sector does not account for it.